Log in to save to my catalogue

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunc...

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fb6358b3e844d6284ce50b1283067ca

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

About this item

Full title

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Publisher

London: BioMed Central

Journal title

Critical care (London, England), 2022-06, Vol.26 (1), p.1-183, Article 183

Language

English

Formats

Publication information

Publisher

London: BioMed Central

More information

Scope and Contents

Contents

Background Clarithromycin may act as immune-regulating treatment in sepsis and acute respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed to evaluate whether clarithromycin improves 28-day mortality among patients with sepsis, respiratory and multiple organ dysfunction syndrome. Methods We conducted a multicen...

Alternative Titles

Full title

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3fb6358b3e844d6284ce50b1283067ca

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fb6358b3e844d6284ce50b1283067ca

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1366-609X,1466-609X

DOI

10.1186/s13054-022-04055-4

How to access this item